Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
537
mi
from 43215
New Haven, CT
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
934
mi
from 43215
Delray Beach, FL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
934
mi
from 43215
Delray Beach, FL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
931
mi
from 43215
West Palm Beach, FL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
658
mi
from 43215
Plymouth, MA
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
658
mi
from 43215
Plymouth, MA
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
442
mi
from 43215
Quincy, MA
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
442
mi
from 43215
Quincy, MA
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Monroe, NJ
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Monroe, NJ
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
513
mi
from 43215
Albany, NY
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
354
mi
from 43215
Durham, NC
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Biella,
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Biella,
Click here to add this to my saved trials
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
Community-based, Buddy-supported Exercise in Patients With MCI: a Pilot Trial
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
306
mi
from 43215
Winston-Salem, NC
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
Community-based, Buddy-supported Exercise in Patients With MCI: a Pilot Trial
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System - American Lake Division
2012
mi
from 43215
Tacoma, WA
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System - American Lake Division
2012
mi
from 43215
Tacoma, WA
Click here to add this to my saved trials
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Hospital
306
mi
from 43215
Winston-Salem, NC
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Hospital
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury
Combining Cognitive Treatment With Noninvasive Brain Stimulation in Blast TBI
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System
643
mi
from 43215
Boston, MA
Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury
Combining Cognitive Treatment With Noninvasive Brain Stimulation in Blast TBI
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury
Combining Cognitive Treatment With Noninvasive Brain Stimulation in Blast TBI
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury
Combining Cognitive Treatment With Noninvasive Brain Stimulation in Blast TBI
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Fluoxetine Prevention Trial
Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment
Status: Enrolling
Updated:  12/31/1969
City of Hope
1955
mi
from 43215
Duarte, CA
Fluoxetine Prevention Trial
Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment
Status: Enrolling
Updated: 12/31/1969
City of Hope
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Fluoxetine Prevention Trial
Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Fluoxetine Prevention Trial
Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression
Status: Enrolling
Updated:  12/31/1969
Stanford University Department of Pscyhiatry and Behavioral Sciences
2101
mi
from 43215
Stanford, CA
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression
Status: Enrolling
Updated: 12/31/1969
Stanford University Department of Pscyhiatry and Behavioral Sciences
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System (VAPAHCS)
2102
mi
from 43215
Palo Alto, CA
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System (VAPAHCS)
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated:  12/31/1969
Yale Child Study Center
537
mi
from 43215
New Haven, CT
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Yale Child Study Center
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms
Behavioral and Neural Indices of Cognitive Rehabilitation in Women's Cancer: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Fred Hutch/University of Washington Cancer Consortium
2003
mi
from 43215
Seattle, WA
Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms
Behavioral and Neural Indices of Cognitive Rehabilitation in Women's Cancer: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
2003
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Brain Imaging for HIV-Associated Thinking and Mood Disorders
Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Brain Imaging for HIV-Associated Thinking and Mood Disorders
Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Indiana University Dementia Screening Trial
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated:  12/31/1969
IU Health-Primary Care Clinics
166
mi
from 43215
Indianapolis, IN
Indiana University Dementia Screening Trial
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
IU Health-Primary Care Clinics
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Indiana University Dementia Screening Trial
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated:  12/31/1969
Wishard Health Services-Primary Care Clinics
166
mi
from 43215
Indianapolis, IN
Indiana University Dementia Screening Trial
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Wishard Health Services-Primary Care Clinics
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Indiana University Dementia Screening Trial
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated:  12/31/1969
IU Health Arnett Primary Care Clinics
207
mi
from 43215
West Lafayette, IN
Indiana University Dementia Screening Trial
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
IU Health Arnett Primary Care Clinics
207
mi
from 43215
West Lafayette, IN
Click here to add this to my saved trials
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
MC1193: Collaborative Care to Preserve Performance in Cancer (COPE)
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
MC1193: Collaborative Care to Preserve Performance in Cancer (COPE)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Arterial Spin Labeling (ASL) MRI for Cognitive Decline
Optimized Arterial Spin Labeling MRI for Cognitive Decline
Status: Enrolling
Updated:  12/31/1969
Penn Memory Center
416
mi
from 43215
Philadelphia, PA
Arterial Spin Labeling (ASL) MRI for Cognitive Decline
Optimized Arterial Spin Labeling MRI for Cognitive Decline
Status: Enrolling
Updated: 12/31/1969
Penn Memory Center
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study
Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital
496
mi
from 43215
Mineola, NY
Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study
Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital
496
mi
from 43215
Mineola, NY
Click here to add this to my saved trials
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
1958
mi
from 43215
Irvine, CA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
1958
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials